Ma H - Search Results

1

Targeting PRAME for acute myeloid leukemia therapy.

Yang J, Chen M, Ye J, Ma H. Yang J, et al. Among authors: ma h. Front Immunol. 2024 Mar 26;15:1378277. doi: 10.3389/fimmu.2024.1378277. eCollection 2024. Front Immunol. 2024. PMID: 38596687 Free PMC article. Review.

2

Adoptive cell therapy for acute myeloid leukemia.

Ma H, Padmanabhan Iyer S, Parmar S, Gong Y. Ma H, et al. Leuk Lymphoma. 2019 Jun;60(6):1370-1380. doi: 10.1080/10428194.2018.1553300. Epub 2019 Jan 10. Leuk Lymphoma. 2019. PMID: 30628504 Review.

3

Targeting CLL-1 for acute myeloid leukemia therapy.

Ma H, Padmanabhan IS, Parmar S, Gong Y. Ma H, et al. J Hematol Oncol. 2019 Apr 24;12(1):41. doi: 10.1186/s13045-019-0726-5. J Hematol Oncol. 2019. PMID: 31014360 Free PMC article. Review.

4

[Efficacy of Different Doses of Daunorubicin Induced Chemotherapy in Patients with Newly Diagnosed Primary Acute Myeloid Leukemia Under 65 Years Old].

Gong SG, Wang FJ, Wang ST, Zheng Q, Shuai X, Ma HB, Zhang L, Chen XC, Wu Y, Jia YQ. Gong SG, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Aug;29(4):1071-1079. doi: 10.19746/j.cnki.issn.1009-2137.2021.04.009. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34362484 Chinese.

5

Targeting CD38 for acute leukemia.

Zhong X, Ma H. Zhong X, et al. Among authors: ma h. Front Oncol. 2022 Oct 12;12:1007783. doi: 10.3389/fonc.2022.1007783. eCollection 2022. Front Oncol. 2022. PMID: 36313735 Free PMC article. Review.

6

Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.

Qin Y, Shen K, Liu T, Ma H. Qin Y, et al. Among authors: ma h. BMC Cancer. 2023 Jun 9;23(1):527. doi: 10.1186/s12885-023-11034-7. BMC Cancer. 2023. PMID: 37291515 Free PMC article.

7

The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.

Yang J, Zhao L, Wu Y, Niu T, Gong Y, Chen X, Huang X, Liu J, Dai Y, Ma H. Yang J, et al. Among authors: ma h. Cancer Med. 2023 Dec;12(23):21111-21117. doi: 10.1002/cam4.6669. Epub 2023 Nov 8. Cancer Med. 2023. PMID: 37937729 Free PMC article.

8

Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study.

Zhao L, Yang J, Chen M, Xiang X, Ma H, Niu T, Gong Y, Chen X, Liu J, Wu Y. Zhao L, et al. Among authors: ma h. Ann Hematol. 2024 Apr;103(4):1197-1209. doi: 10.1007/s00277-024-05646-7. Epub 2024 Feb 8. Ann Hematol. 2024. PMID: 38329487

9

Intravascular large B-cell lymphoma as a covert trigger for hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome: a case report and literature review.

Wen J, Xu J, Ji J, Zhang W, Zheng Q, Liu T, Zheng Y, Ma H. Wen J, et al. Among authors: ma h. Front Immunol. 2024 Jul 12;15:1403376. doi: 10.3389/fimmu.2024.1403376. eCollection 2024. Front Immunol. 2024. PMID: 39072323 Free PMC article. Review.

10

Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemia.

Zhong X, Wang J, Dai Y, Huang X, Liu J, Xiang B, Ma H. Zhong X, et al. Among authors: ma h. Hematology. 2024 Dec;29(1):2433172. doi: 10.1080/16078454.2024.2433172. Epub 2024 Nov 25. Hematology. 2024. PMID: 39585800 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,237 results

Search Page

Filters